Home Page

Emergent's mission is simple—
to protect and enhance life.

As a global specialty pharmaceutical company,
Emergent offers specialized products to
healthcare providers and governments to
address medical needs and emerging
health threats.

Learn More

FDA Approves
BioThrax for
Post-Exposure
Prophylaxis

LEARN MORE ▶

Emergent BioSolutions
announces plan to implement
tax-free spin-off of Biosciences
business into a separate
publicly-traded company.

LEARN MORE ▶


Emergent
Launches
IXINITY®

LEARN MORE ▶

Meet Us

  • Investor Relations

    JPMorgan Healthcare Conference
    January 11-14, 2016
    San Francisco, CA

  • Investor Relations

    RBC Healthcare Conference
    February 23-24, 2016
    New York, NY


     

  • Investor Relations

    Cowen & Co. Annual Health Care Conference
    March 7-9, 2016
    Boston, MA

Price $35.78 -1.09 (-2.96%)
 Feb 5 2016 4:02PM

REFRESH